The number of lawsuits over the diabetes drug Invokana is increasing nationwide, and attorneys who work in the area expect a significant chunk of the litigation to come to Pennsylvania.
April 25, 2016 at 03:35 PM
1 minute read
The number of lawsuits over the diabetes drug Invokana is increasing nationwide, and attorneys who work in the area expect a significant chunk of the litigation to come to Pennsylvania.
According to court records, at least 15 cases alleging injuries related to Invokana have been filed in the Philadelphia Court of Common Pleas since December.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
The premier educational and networking event for employee benefits brokers and agents.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
